We are Sorry, This Page doesn't Exist
Gulfport divests non-core assets for $100M, updates accretive debt repurchases
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea initiated with a Buy at H.C. Wainwright
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Esco Technologies divests technical packaging business segment to Sonoco
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea Biopharmaceuticals" (NAVB) CEO Jed Latkin on Q3 2019 Results - Earnings Call Transcript
Navidea Biopharmaceuticals" (NAVB) CEO Jed Latkin on Q3 2019 Results - Earnings Call Transcript.....»»
Navidea, IMV Inc. enter research collaboration to explore immunotherapies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea says NAV3-31 Phase 2B study data supports hypotheses
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 14.) read more.....»»
The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 14.) Natera Inc (NASDAQ: NTRA) Ra Pharmaceuticals Inc (NASDAQ: RARX) Reata Pharmaceuticals Inc (.....»»
Aclaris Therapeutics divests Rhofade
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea management to meet with Maxim
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Rollins divests $200M pension liability, sees 12c per share impact in Q3
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
LKQ divests majority of Bulgarian business through merger
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca divests rights for Losec to Cheplapharm
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea receives $225,000 grant from NIH for Gallium 68 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Navidea Biopharmaceuticals (NAVB) Investor Presentation - Slideshow
Navidea Biopharmaceuticals (NAVB) Investor Presentation - Slideshow.....»»
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2019 Results - Earnings Call Transcript
Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin on Q2 2019 Results - Earnings Call Transcript.....»»
JMU divests food supply chain business
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ideanomics divests majority stake in Amer Global into IOT startup with 2020 IPO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
What Caused The Opening Gap In Navidea Biopharmaceuticals?
For real-time updates on NAVB, beat the news and login or try Benzinga Pro. Biotechnology company that specializes in precision medicine, Navidea Biopharmaceuticals Inc (NYSE: NAVB) today had a large opening gap of 23.84%. read more.....»»